🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/07/2011 | 34,10 | 34,38 | 33,95 | 34,00 | -0,14% | 1,26% | 12.410.835 |
| 11/07/2011 | 34,31 | 34,31 | 33,88 | 34,05 | -1,22% | 1,25% | 10.741.895 |
| 08/07/2011 | 34,24 | 34,53 | 34,13 | 34,47 | +1,09% | 1,17% | 15.752.383 |
| 07/07/2011 | 34,12 | 34,30 | 33,83 | 34,09 | +0,56% | 1,40% | 12.800.482 |
| 06/07/2011 | 33,87 | 33,99 | 33,75 | 33,90 | +0,11% | 0,70% | 11.326.050 |
| 05/07/2011 | 33,88 | 34,06 | 33,82 | 33,86 | -0,31% | 0,70% | 9.417.747 |
| 01/07/2011 | 33,56 | 34,09 | 33,55 | 33,97 | +0,88% | 1,62% | 10.356.231 |
| 30/06/2011 | 33,61 | 33,85 | 33,49 | 33,67 | +0,54% | 1,05% | 13.363.258 |
| 29/06/2011 | 33,35 | 33,67 | 33,23 | 33,49 | +0,54% | 1,34% | 13.420.793 |
| 28/06/2011 | 33,01 | 33,40 | 32,92 | 33,31 | +1,10% | 1,45% | 10.468.577 |
| 27/06/2011 | 33,06 | 33,11 | 32,80 | 32,95 | -0,06% | 0,95% | 11.374.887 |
| 24/06/2011 | 33,42 | 33,46 | 32,92 | 32,97 | -1,20% | 1,63% | 17.395.647 |
| 23/06/2011 | 33,52 | 33,70 | 32,96 | 33,37 | -1,41% | 2,22% | 20.409.695 |
| 22/06/2011 | 33,94 | 34,06 | 33,80 | 33,85 | -0,87% | 0,79% | 8.071.277 |
| 21/06/2011 | 34,27 | 34,32 | 33,98 | 34,14 | -0,03% | 1,00% | 9.013.953 |
| 20/06/2011 | 33,67 | 34,17 | 33,61 | 34,15 | +1,13% | 1,67% | 11.300.165 |
| 17/06/2011 | 33,78 | 34,13 | 33,57 | 33,77 | +0,60% | 1,67% | 15.770.828 |
| 16/06/2011 | 33,53 | 33,74 | 33,40 | 33,57 | +0,03% | 1,02% | 10.610.057 |
| 15/06/2011 | 33,85 | 33,85 | 33,39 | 33,56 | -1,32% | 1,35% | 12.733.305 |
| 14/06/2011 | 33,88 | 34,24 | 33,71 | 34,01 | +0,88% | 1,55% | 13.224.607 |
| 13/06/2011 | 33,43 | 33,86 | 33,43 | 33,71 | -0,34% | 1,31% | 8.365.136 |
| 10/06/2011 | 34,24 | 34,24 | 33,74 | 33,83 | -1,53% | 1,45% | 12.472.248 |
| 09/06/2011 | 34,24 | 34,71 | 34,15 | 34,35 | +0,59% | 1,64% | 14.247.979 |
| 08/06/2011 | 33,90 | 34,30 | 33,85 | 34,15 | +0,62% | 1,35% | 12.646.635 |
| 07/06/2011 | 34,17 | 34,47 | 33,93 | 33,94 | +0,03% | 1,56% | 10.531.457 |
| 06/06/2011 | 34,06 | 34,19 | 33,86 | 33,93 | -0,73% | 0,95% | 10.100.310 |
| 03/06/2011 | 34,15 | 34,38 | 34,12 | 34,18 | -0,91% | 0,75% | 10.359.690 |
| 02/06/2011 | 34,52 | 34,59 | 34,28 | 34,49 | -0,28% | 0,88% | 11.086.478 |
| 01/06/2011 | 34,92 | 35,07 | 34,54 | 34,59 | -1,36% | 1,50% | 11.847.011 |
| 31/05/2011 | 34,72 | 35,08 | 34,68 | 35,07 | +1,49% | 1,15% | 15.506.732 |